Explore / Clinical trial
Clinical trial

Safety for Home Administration of Microdose Psilocybin Use

Johns Hopkins UniversityCompletedPhase 1Started Dec 6, 202417 enrolledUnited StatesNCT06450210

Abstract

The goal of this laboratory study is to establish whether and which microdoses of psilocybin are safe to administer at home to healthy participants. Eligible participants will be given ascending doses of psilocybin trihydrate and a single, interspersed, randomized placebo on separate days in double-blind fashion. The participants will be asked to complete questionnaires and undergo safety assessments.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psilocybin

Keywords

Psychedelic Experiences

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.